Peeling Sesderma Azelac Peel

Do acne marks and blemishes bother you and are you looking for a peel that will relieve you of this problem and is well tolerated by people with very sensitive skin? The Sesderma Azelac Peel peel based on azelaic acid is perfect for you.

The Azelac line lightens, reduces, and prevents skin discoloration of various origins. The product is specially designed for the needs of skin with pigmentation disorders and signs of photoaging. It is also recommended for post-inflammatory hyperpigmentation that occurs in areas where acne was previously present.

The peel contains brightening agents such as azelaic acid, 4-butyl resorcinol, and, most recently, plant growth factors, which not only reduce the symptoms of photoaging but also wrinkles.

The Azelac range uses nanotechnology to allow the ingredients to penetrate deep into the dermis of the skin, providing an intense depigmenting effect.

Before each chemical peeling procedure with Sesderma products, a cosmetologist consults with a doctor to exclude possible contraindications.

The procedure consists of several stages:

• Firstly, a thorough make-up removal and cleansing of the face is performed. It is very important to thoroughly degrease the skin with a degreasing liquid to ensure proper and even penetration of acids throughout the treated area.
• Next, the eyes and sensitive areas are protected and the appropriate product is applied. The aesthetician selects it according to the type, thickness, and condition of the skin, both the peel and its concentration, as well as the time and technique of application. After the appropriate exposure time, the product is washed off and the skin is neutralized with a neutralizing liquid.
• The final stage of the procedure is the application of a special regenerating cream and sunscreen.

Recommended frequency: 4-6 treatments every 14-21 days. The number of treatments depends on the improvement of the skin condition. Year-round treatment

• Post-inflammatory hyperpigmentation
• Acne vulgaris
• Depigmentation

• Pregnancy and breastfeeding
• Active cancer and the period of 5 years after it
• Infections
• Allergy to any component of the drug
• Inflammatory skin diseases
• Immunosuppressive diseases
• Other medical contraindications